179 related articles for article (PubMed ID: 33468990)
1. AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma.
Zheng D; Liu W; Xie W; Huang G; Jiang Q; Yang Y; Huang J; Xing Z; Yuan M; Wei M; Li Y; Yin J; Shen J; Shi Z
Signal Transduct Target Ther; 2021 Jan; 6(1):25. PubMed ID: 33468990
[TBL] [Abstract][Full Text] [Related]
2. Up-regulated isocitrate dehydrogenase 1 suppresses proliferation, migration and invasion in osteosarcoma: in vitro and in vivo.
Hu X; Liu Y; Qin C; Pan Z; Luo J; Yu A; Cheng Z
Cancer Lett; 2014 Apr; 346(1):114-21. PubMed ID: 24368190
[TBL] [Abstract][Full Text] [Related]
3. SIX4 upregulates IDH1 and metabolic reprogramming to promote osteosarcoma progression.
Li B; Dang X; Duan J; Zhang G; Zhang J; Song Q
J Cell Mol Med; 2023 Jan; 27(2):259-265. PubMed ID: 36601689
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 promotes metastasis of human osteosarcoma cells.
Zhang N; Xie T; Xian M; Wang YJ; Li HY; Ying MD; Ye ZM
Oncotarget; 2016 Nov; 7(48):79654-79669. PubMed ID: 27793039
[TBL] [Abstract][Full Text] [Related]
5. PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway.
Li L; Liang S; Wasylishen AR; Zhang Y; Yang X; Zhou B; Shan L; Han X; Mu T; Wang G; Xiong S
Oncotarget; 2016 Apr; 7(14):18021-35. PubMed ID: 26933804
[TBL] [Abstract][Full Text] [Related]
6. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract][Full Text] [Related]
7. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
8. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.
Ren K; Zhang J; Gu X; Wu S; Shi X; Ni Y; Chen Y; Lu J; Gao Z; Wang C; Yao N
Exp Cell Res; 2018 Aug; 369(1):80-89. PubMed ID: 29750896
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.
Su Y; Zhou Y; Sun YJ; Wang YL; Yin JY; Huang YJ; Zhang JJ; He AN; Han K; Zhang HZ; Yao Y; Lv XB; Hu HY
J Mol Med (Berl); 2019 Jan; 97(1):49-61. PubMed ID: 30426155
[TBL] [Abstract][Full Text] [Related]
10. EMP1 promotes the malignant progression of osteosarcoma through the IRX2/MMP9 axis.
Wang M; Liu T; Hu X; Yin A; Liu J; Wang X
Panminerva Med; 2020 Sep; 62(3):150-154. PubMed ID: 32716150
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
Chen F; Mo J; Zhang L
Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
[TBL] [Abstract][Full Text] [Related]
12. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.
Wang W; Zhou X; Wei M
Oncotarget; 2015 Apr; 6(12):10297-308. PubMed ID: 25912304
[TBL] [Abstract][Full Text] [Related]
14. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells.
Liu W; Jiang D; Gong F; Huang Y; Luo Y; Rong Y; Wang J; Ge X; Ji C; Fan J; Cai W
Cell Death Dis; 2020 Feb; 11(2):93. PubMed ID: 32024814
[TBL] [Abstract][Full Text] [Related]
15. MAT1 facilitates the lung metastasis of osteosarcoma through upregulation of AKT1 expression.
Wang J; Ni J; Song D; Ding M; Huang J; Li W; He G
Life Sci; 2019 Oct; 234():116771. PubMed ID: 31421084
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis.
Xia P; Gu R; Zhang W; Shao L; Li F; Wu C; Sun Y
J Cell Physiol; 2019 Dec; 234(12):22787-22798. PubMed ID: 31152456
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
[TBL] [Abstract][Full Text] [Related]
18. CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.
Tang Q; Lu J; Zou C; Shao Y; Chen Y; Narala S; Fang H; Xu H; Wang J; Shen J; Khokha R
Oncogene; 2018 Jul; 37(27):3617-3630. PubMed ID: 29610525
[TBL] [Abstract][Full Text] [Related]
19. Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcoma.
Zhou Y; Shen JK; Yu Z; Hornicek FJ; Kan Q; Duan Z
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1573-1582. PubMed ID: 29452249
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
